SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
SEC Accession No. 0001140361-23-002442
Filing Date
2023-01-23
Accepted
2023-01-23 17:22:34
Documents
1
Group Members
SUMITOMO PHARMA CO. LTD.SUMITOVANT BIOPHARMA LTD.ZEUS SCIENCES LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13E3/A ny20005635x11_sc13e3a.htm SC 13E3/A 361985
  Complete submission text file 0001140361-23-002442.txt   363751
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44 207-400-3351
Myovant Sciences Ltd. (Filed by) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: SC 13E3/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44 207-400-3351
Myovant Sciences Ltd. (Subject) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: SC 13E3/A | Act: 34 | File No.: 005-89732 | Film No.: 23545282
SIC: 2834 Pharmaceutical Preparations